OPCH
OPTION CARE HEALTH, INC.Marquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Duquesne Family Office re-entered | Q1 2021 | 22Q | $20 | $20 | -1% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $31 | $20 | -36% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $31 | $20 | -36% |
| D.E. Shaw re-entered | Q3 2024(8Q snapshot) | 7Q | $31 | $20 | -36% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $31 | $20 | -36% |
| Renaissance Technologies | Q4 2024(8Q snapshot) | 6Q | $22 | $20 | -11% |
| Point72 Asset Management re-entered | Q4 2024(8Q snapshot) | 6Q | $22 | $20 | -11% |
| AQR Capital Management | Q1 2025(8Q snapshot) | 5Q | $31 | $20 | -37% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates | Q4 2023 | Q1 2026 | → $35 | +25% |
| Third Point 2× in & out | Q3 2023 | Q1 2024 | → $33 | -6% |
| Viking Global Investors | Q2 2023 | Q3 2023 | → $35 | +30% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Option Care Health, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 22, 2026 — the most recent Form 4 on file — not from today.
- Form 40001437749-26-018303May 22, 2026
- Form 40001437749-26-018302May 22, 2026
- Form 40001437749-26-018301May 22, 2026
- Form 40001437749-26-018300May 22, 2026
- Form 40001437749-26-018299May 22, 2026
- Form 40001437749-26-018298May 22, 2026
- Form 40001437749-26-018297May 22, 2026
- Form 40001437749-26-018296May 22, 2026
- Form 40001437749-26-018065May 21, 2026
- Form 40001437749-26-015657May 7, 2026
- Form 40001437749-26-014959May 5, 2026
- Form 40001437749-26-014693May 4, 2026
- Form 40001437749-26-014692May 4, 2026
- Form 40001437749-26-013334Apr 24, 2026
- Form 40001437749-26-006650Mar 3, 2026
Fundamentals
XBRL · OPTION CARE HEALTH, INC.Annual figures sourced directly from OPTION CARE HEALTH, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Option Care Health, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 22, 2026
- 8-KFORM 8-KMay 12, 2026
- 8-KMaterial eventMay 5, 2026
- 10-QQuarterly reportApr 30, 2026
- 8-KFORM 8-KApr 30, 2026
- DEF 14AProxy statementApr 8, 2026
- 8-KFORM 8-KApr 2, 2026
- 10-KAnnual reportFeb 24, 2026
- 8-KMaterial eventFeb 24, 2026
- 8-KFORM 8-KJan 12, 2026
- 10-QQuarterly reportOct 30, 2025
- 8-KMaterial eventOct 30, 2025
- 8-KFORM 8-KSep 25, 2025
- 8-KFORM 8-KAug 20, 2025
- 10-QQuarterly reportJul 30, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Point72 Asset Management | Q1 2026 | open | $35 | $20 | -44% |
| Duquesne Family Office | Q3 2025 | open | $28 | $20 | -30% |
| Point72 Asset Management | Q2 2025 | Q3 2025 | $32 | $28 | -13% |
| D.E. Shaw | Q1 2025 | open | $31 | $20 | -37% |
| AQR Capital Management | Q1 2025 | open | $31 | $20 | -37% |
| Point72 Asset Management | Q4 2024 | Q1 2025 | $22 | $31 | +42% |
| Renaissance Technologies | Q4 2024 | open | $22 | $20 | -11% |
| Citadel Advisors | Q3 2024 | open | $31 | $20 | -36% |
| Two Sigma Investments | Q3 2024 | open | $31 | $20 | -36% |
| D.E. Shaw | Q3 2024 | Q4 2024 | $31 | $22 | -28% |
| Millennium Management | Q3 2024 | open | $31 | $20 | -36% |
| Bridgewater Associates | Q4 2023 | Q1 2026 | $28 | $35 | +25% |
| Third Point | Q3 2023 | Q1 2024 | $35 | $33 | -6% |
| Viking Global Investors | Q2 2023 | Q3 2023 | $27 | $35 | +30% |
| Duquesne Family Office | Q4 2022 | Q4 2024 | $30 | $22 | -26% |
| Third Point | Q4 2021 | Q1 2022 | $27 | $24 | -11% |
| Duquesne Family Office | Q1 2021 | Q3 2022 | $20 | $35 | +77% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.